Last reviewed · How we verify
UC-MSCs and Secretomes — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
UC-MSCs and Secretomes (UC-MSCs and Secretomes) — PT. Prodia Stem Cell Indonesia.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| UC-MSCs and Secretomes TARGET | UC-MSCs and Secretomes | PT. Prodia Stem Cell Indonesia | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- UC-MSCs and Secretomes CI watch — RSS
- UC-MSCs and Secretomes CI watch — Atom
- UC-MSCs and Secretomes CI watch — JSON
- UC-MSCs and Secretomes alone — RSS
Cite this brief
Drug Landscape (2026). UC-MSCs and Secretomes — Competitive Intelligence Brief. https://druglandscape.com/ci/uc-mscs-and-secretomes. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab